309P Pneumonitis and Corticosteroid Treatment in Patients with Unresectable Non-Small Cell Lung Cancer Receiving Durvalumab Consolidation after Definitive Chemoradiotherapy
Annals of oncology(2022)
摘要
Durvalumab consolidation after definitive chemoradiotherapy (CRT) is the standard of care for locally advanced, unresectable non-small cell lung cancer (NSCLC). Clinicopathological features of pneumonitis and its treatment using corticosteroid have not been adequately investigated.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要